Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
Aniline Compounds
/ pharmacology
Animals
Brain
/ diagnostic imaging
Contrast Media
Disease Models, Animal
Drug Therapy, Combination
/ methods
Encephalomyelitis, Autoimmune, Experimental
/ diagnostic imaging
Female
Gadolinium
Glatiramer Acetate
/ pharmacology
Image Enhancement
/ methods
Immunosuppressive Agents
/ pharmacology
Magnetic Resonance Imaging
/ methods
Mice
Peroxidase
/ drug effects
Saline Solution
/ administration & dosage
Journal
Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
4
9
2019
medline:
11
3
2020
entrez:
4
9
2019
Statut:
ppublish
Résumé
Background Despite advances in immunomodulatory agents, most current therapies for multiple sclerosis target lymphocytes or lymphocytic function. However, therapy response may be less than optimal due to demyelination and axonal damage caused by myeloid cells. Purpose To determine if myeloperoxidase (MPO) molecular MRI can evaluate whether combination therapy targeting both lymphoid and myeloid inflammation can improve autoimmune neuroinflammation compared with either drug alone, even at suboptimal doses. Materials and Methods Four groups of 94 female mice (8-10 weeks old) were induced with experimental autoimmune encephalomyelitis (EAE) from August 2, 2016, to March 30, 2018, and divided into saline control (
Identifiants
pubmed: 31478802
doi: 10.1148/radiol.2019182492
pmc: PMC6776885
doi:
Substances chimiques
Aniline Compounds
0
Contrast Media
0
Immunosuppressive Agents
0
Saline Solution
0
4-aminobenzhydrazide
5351-17-7
Glatiramer Acetate
5M691HL4BO
Gadolinium
AU0V1LM3JT
Peroxidase
EC 1.11.1.7
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
158-165Subventions
Organisme : NINDS NIH HHS
ID : R01 NS103998
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS070835
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Mol Neurobiol. 2019 Feb;56(2):954-962
pubmed: 29808380
J Immunol. 2010 Mar 15;184(6):3174-85
pubmed: 20173032
Am J Respir Crit Care Med. 2012 Jan 1;185(1):34-43
pubmed: 21997333
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11358-63
pubmed: 18678887
J Am Chem Soc. 2010 Jan 13;132(1):168-77
pubmed: 19968300
Brain. 2008 Apr;131(Pt 4):1123-33
pubmed: 18234693
Radiology. 2012 May;263(2):451-60
pubmed: 22438365
J Clin Invest. 2010 Jul;120(7):2627-34
pubmed: 20577051
Circulation. 2008 Mar 4;117(9):1153-60
pubmed: 18268141
N Engl J Med. 2006 Mar 2;354(9):942-55
pubmed: 16510748
Exp Gerontol. 2001 Dec;37(1):137-48
pubmed: 11738154
Annu Rev Immunol. 2005;23:683-747
pubmed: 15771584
N Engl J Med. 2006 Mar 2;354(9):899-910
pubmed: 16510744
J Pharmacol Exp Ther. 2015 May;353(2):288-98
pubmed: 25698787
Nat Med. 2007 Aug;13(8):935-43
pubmed: 17676050
Neurology. 1995 Jul;45(7):1268-76
pubmed: 7617181
Science. 2016 Aug 19;353(6301):777-83
pubmed: 27540165
Heart Vessels. 2012 Sep;27(5):468-74
pubmed: 21837497
Radiology. 2015 May;275(2):480-9
pubmed: 25494298
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18584-9
pubmed: 19011099
Neurology. 1993 Apr;43(4):662-7
pubmed: 8469319
Brain. 2004 Jun;127(Pt 6):1370-8
pubmed: 15090474
Radiology. 2006 Aug;240(2):473-81
pubmed: 16864673
J Immunol. 1996 Sep 15;157(6):2660-5
pubmed: 8805671
Radiology. 2017 Aug;284(2):390-400
pubmed: 28358240
Brain Pathol. 2008 Jan;18(1):86-95
pubmed: 18042261
Eur Heart J. 2018 Sep 14;39(35):3301-3310
pubmed: 30219874
Circulation. 2009 Aug 18;120(7):592-9
pubmed: 19652086
Biochem J. 1995 Jun 1;308 ( Pt 2):559-63
pubmed: 7772042